Retroviral Vectors for Production of Interleukin‐12 in the Bone Marrow to Induce a Graft‐Versus‐Leukemia Effecta
- 1 October 1996
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 795 (1) , 341-345
- https://doi.org/10.1111/j.1749-6632.1996.tb52687.x
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Therapeutic potential of retroviral vectorsTransfusion Science, 1996
- Interleukin-12: A Proinflammatory Cytokine with Immunoregulatory Functions that Bridge Innate Resistance and Antigen-Specific Adaptive ImmunityAnnual Review of Immunology, 1995
- CD4 T cells inhibitin vivo the CD8-mediated immune response against murine colon carcinoma cells transduced with interleukin-12 genesEuropean Journal of Immunology, 1995
- Construction and Characterization of Retroviral Vectors Expressing Biologically Active Human Interleukin-12Human Gene Therapy, 1994
- Antitumor and antimetastatic activity of interleukin 12 against murine tumors.The Journal of Experimental Medicine, 1993
- Progenitor cell hyperplasia with rare development of myeloid leukemia in interleukin 11 bone marrow chimeras.The Journal of Experimental Medicine, 1993
- Cytotoxic lymphocyte maturation factor (interleukin 12) is a synergistic growth factor for hematopoietic stem cells.The Journal of Experimental Medicine, 1993
- Transplantable myeloproliferative disease induced in mice by an interleukin 6 retrovirus.The Journal of Experimental Medicine, 1992
- In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain TumorsScience, 1992
- Expression of Retrovirally Transduced IL-1 α in IL-6-Dependent B Cells: A Murine Model of Aggressive Multiple MyelomaGrowth Factors, 1991